The first ever drug specifically designed to prevent migraines in adults has been approved by the European Medicines Agency (EMA), and the head of the Oxford Headache Centre has said the news represents a new approach in treating the condition. The EMA granted a licence for the use of erenumab, ... READ MORE
News
Knowing you are pre-diabetic does not usually lead to changes in lifestyle, study finds
Social and cultural factors mean that people who are told they are pre-diabetic are too often unable to make the necessary lifestyle changes to prevent progression to diabetes, according to a study by researchers supported by the NIHR oxford Biomedical Research Centre. The study, ‘How are ... READ MORE
Researchers map leukaemia ‘family trees’ in patients treated with new drug
A team of international researchers, including experts from NIHR Oxford BRC, has for the first time mapped the family trees of cancer cells in acute myeloid leukaemia (AML) to understand how this blood cancer responds to a new drug, enasidenib. The work also explains what happens when a patient ... READ MORE
One dose of aspirin doesn’t fit all
About one billion people worldwide take regular aspirin, usually to prevent heart attacks or strokes. Writing in The Lancet, researchers have shown that ‘one-dose-fits-all’ use of aspirin to prevent heart attacks, stroke or cancer, is ineffective or harmful in the majority of people, and that a ... READ MORE
Pregnant women invited to take part in pioneering diabetes prevention research
Pregnant women are being invited by the University of Oxford and the NHS to take part in the world’s first clinical trial to prevent type 1 diabetes in babies and infants. Researchers supported by the NIHR Oxford Biomedical Research Centre want to find out if giving small amounts of insulin to ... READ MORE
Ultrasound and nanomedicine offer new hope for improving effects of cancer drugs
In a breakthrough that allows the more precise targeting of drugs at cancers, a University of Oxford team has used ultrasound and lipid drug carriers to remotely trigger and enhance the delivery of a cancer drug in humans for the first time. The study was conducted by researchers from the ... READ MORE
#OxfordImpact2018
Post by Prof Trish Greenhalgh, NIHR Oxford BRC Theme Lead for Partnerships for Health, Wealth and Innovation The most memorable sentence from this one-day workshop held at Jesus College, Oxford, on 21 June 2018 was from keynote speaker Mark Taylor. Reflecting on his experience as a patient with ... READ MORE
Oxford Impact 2018 workshop
Last month, the NIHR Oxford BRC and the UK Cochrane Collaboration organised the Oxford Impact 2018 workshop, which brought together people from a wide range of fields to “think differently about research impact”. The event sought to tackle one of the central challenges of what has become known as ... READ MORE
More awareness needed about stroke risk after mini-stroke, study finds
A leading Oxford stroke specialist says more needs to be done to raise of awareness of the need to take rapid action after a mini-stroke in order to reduce the number of major strokes. The study of more than 2,200 patients across Oxfordshire was led by Prof Peter Rothwell (right), of the Nuffield ... READ MORE
BRC visited by senior DHSC figure
The Department of Health and Social Care’s Chief Scientific Adviser, Prof Chris Whitty, visited Oxford on Monday 2nd July to find out about the world-leading research taking place there and to meet young medical researchers starting out on their career. After a meeting at the John Radcliffe ... READ MORE
- « Previous Page
- 1
- …
- 52
- 53
- 54
- 55
- 56
- …
- 90
- Next Page »